Gateway 2011: AMRI - Pharmaceutical Technology

Latest Issue

Latest Issue
PharmTech Europe

Gateway 2011: AMRI

Your online Gateway to AMRI in 2011

26 Corporate Circle
Albany, NY  12203
US: (518) 512-2000
Europe: +44 (0)1352 717100

About AMRI

AMRI is a global contract research and manufacturing organization with twenty years experience providing customers fully integrated lead discovery, development and manufacturing services. The company has steadily expanded, with more than 1400 employees located in facilities throughout the U.S., Europe and Asia


Its diverse customer portfolio includes companies in the pharmaceutical, specialty chemical, biotech, cosmetic, agriculture and food/beverage industries, as well as not-for-profit organizations, universities and medical institutions.
United in vision to provide the highest quality customer service experience, AMRI employees worldwide work together to provide scientific solutions that improve the quality of life.

New Whitepapers
AMRI Aseptic Fill and Finish Services
Formulations Capabilities at AMRI




blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
| Weekly

Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatcchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Medicare Payment Data Raises Questions About Drug Costs
FDA Wants You!
A New Strategy to Tackle Antibiotic Resistance
Drug-Diagnostic Development Stymied by Payer Concerns
Obama Administration Halts Attack on Medicare Drug Plans

Click here